Menu Search
Equities

Thyrocare Technologies Ltd

THYROCARE:NSI

Thyrocare Technologies Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)976.55
  • Today's Change35.55 / 3.78%
  • Shares traded140.54k
  • 1 Year change+80.18%
  • Beta0.5096
Data delayed at least 15 minutes, as of Nov 14 2024 10:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Thyrocare Technologies Ltd grew revenues 8.58% from 5.27bn to 5.72bn while net income improved 9.72% from 644.90m to 707.60m.
Gross margin70.89%
Net profit margin13.20%
Operating margin17.06%
Return on assets13.83%
Return on equity17.24%
Return on investment16.07%
More ▼

Cash flow in INRView more

In 2024, cash reserves at Thyrocare Technologies Ltd fell by 84.70m. However, the company earned 1.68bn from its operations for a Cash Flow Margin of 29.31%. In addition the company used 912.80m on investing activities and also paid 848.10m in financing cash flows.
Cash flow per share24.95
Price/Cash flow per share37.61
Book value per share92.19
Tangible book value per share71.79
More ▼

Balance sheet in INRView more

Thyrocare Technologies Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 3.66%.
Current ratio2.58
Quick ratio2.12
Total debt/total equity0.038
Total debt/total capital0.0366
More ▼

Growth rates in INR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 9.88%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
Div yield(5 year avg)2.54%
Div growth rate (5 year)-2.09%
Payout ratio (TTM)113.51%
EPS growth(5 years)-3.46
EPS (TTM) vs
TTM 1 year ago		28.65
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.